作者
A. Jay Freeman,Kenneth W. Ng,Fuchenchu Wang,Maisam Abu‐El‐Haija,Ankur Chugh,Gretchen A. Cress,Douglas S. Fishman,Cheryl E. Gariepy,Matthew J. Giefer,Praveen S. Goday,Tanja Gonska,Amit S. Grover,Douglas Lindblad,Quin Liu,Asim Maqbool,Jacob Mark,Brian A. McFerron,Megha Mehta,Véronique D. Morinville,Robert A. Noel,Chee Y. Ooi,Emily R. Perito,Sarah Jane Schwarzenberg,Zachary M. Sellers,Michael Wilschanski,Yuhua Zheng,Ying Yuan,Dana K. Andersen,Mark E. Lowe,Aliye Uç
摘要
Among children who suffer from acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP), acute pancreatitis (AP) episodes are painful, often require hospitalization, and contribute to disease complications and progression. Despite this recognition, there are currently no interventions to prevent AP episodes. In this retrospective cohort study, we assessed the impact of pancreatic enzyme therapy (PERT) use on clinical outcomes among children with pancreatic-sufficient ARP or CP.